Ping Cheng

1.4k total citations · 1 hit paper
27 papers, 1.1k citations indexed

About

Ping Cheng is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Ping Cheng has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ping Cheng's work include Liver Disease Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (4 papers) and Autophagy in Disease and Therapy (4 papers). Ping Cheng is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (4 papers) and Autophagy in Disease and Therapy (4 papers). Ping Cheng collaborates with scholars based in China and United States. Ping Cheng's co-authors include Chuanyong Guo, Weiqi Dai, Miao Shen, Jie Lu, Yingqun Zhou, Chengfen Wang, Kan Chen, Ling Xu, Jingjing Li and Fan Wang and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ping Cheng

25 papers receiving 1.1k citations

Hit Papers

Roles of human papillomavirus in cancers: oncogenic mecha... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Cheng China 20 468 319 221 216 147 27 1.1k
Laura Conde de la Rosa United States 18 515 1.1× 458 1.4× 244 1.1× 258 1.2× 150 1.0× 23 1.3k
Chengfen Wang China 20 364 0.8× 339 1.1× 131 0.6× 247 1.1× 131 0.9× 21 961
Raúl González Spain 18 476 1.0× 345 1.1× 163 0.7× 182 0.8× 126 0.9× 37 1.2k
Gustavo Ferrín Spain 19 491 1.0× 213 0.7× 189 0.9× 306 1.4× 139 0.9× 37 1.1k
Inmaculada García‐Ruiz Spain 19 510 1.1× 508 1.6× 130 0.6× 141 0.7× 132 0.9× 35 1.2k
Hanyong Sun China 13 413 0.9× 356 1.1× 210 1.0× 171 0.8× 136 0.9× 21 1.0k
Ei Kataoka Japan 14 508 1.1× 409 1.3× 97 0.4× 228 1.1× 172 1.2× 18 1.0k
Wenhui Mo China 17 651 1.4× 337 1.1× 124 0.6× 226 1.0× 414 2.8× 43 1.3k
Monica Pibiri Italy 23 685 1.5× 322 1.0× 221 1.0× 353 1.6× 157 1.1× 40 1.4k
Bryan Mackowiak United States 15 425 0.9× 341 1.1× 108 0.5× 135 0.6× 273 1.9× 29 1.1k

Countries citing papers authored by Ping Cheng

Since Specialization
Citations

This map shows the geographic impact of Ping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Cheng more than expected).

Fields of papers citing papers by Ping Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Cheng. The network helps show where Ping Cheng may publish in the future.

Co-authorship network of co-authors of Ping Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Cheng. A scholar is included among the top collaborators of Ping Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Cheng. Ping Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yu, Ke Qiu, Jianjun Ren, Yu Zhao, & Ping Cheng. (2025). Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. Signal Transduction and Targeted Therapy. 10(1). 44–44. 17 indexed citations breakdown →
2.
Qiu, Ke, Maosen Xu, Aqu Alu, et al.. (2025). Ad‐E6/7‐HR vaccine improves the prophylactic and therapeutic efficacy in HPV‐associated cancers. Clinical and Translational Medicine. 15(4). e70305–e70305.
4.
Cheng, Ping, Weiqi Dai, Jie Ji, et al.. (2021). Fenofibrate Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice: Involvements of Apoptosis, Autophagy, and PPAR-α Activation. PPAR Research. 2021. 1–16. 14 indexed citations
5.
Wu, Liwei, Qiang Yu, Ping Cheng, & Chuanyong Guo. (2021). PPARγ Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway. PPAR Research. 2021. 1–15. 6 indexed citations
6.
Yang, Jing, Jingjing Li, Weiqi Dai, et al.. (2015). Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis. Experimental and Therapeutic Medicine. 9(4). 1413–1420. 23 indexed citations
7.
8.
Shen, Miao, Jie Lu, Ping Cheng, et al.. (2014). Ethyl Pyruvate Pretreatment Attenuates Concanavalin A-Induced Autoimmune Hepatitis in Mice. PLoS ONE. 9(2). e87977–e87977. 32 indexed citations
9.
Wang, Chengfen, Kan Chen, Yujing Xia, et al.. (2014). N-Acetylcysteine Attenuates Ischemia-Reperfusion-Induced Apoptosis and Autophagy in Mouse Liver via Regulation of the ROS/JNK/Bcl-2 Pathway. PLoS ONE. 9(9). e108855–e108855. 92 indexed citations
10.
Guo, Chuanyong, Ping Cheng, Kan Chen, et al.. (2014). Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis. Drug Design Development and Therapy. 8. 1277–1277. 28 indexed citations
11.
Wang, Fan, Weiqi Dai, Yugang Wang, et al.. (2014). The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma. PLoS ONE. 9(5). e97414–e97414. 48 indexed citations
12.
Zhu, Rong, Jing Yang, Ling Xu, et al.. (2014). Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis. Gastroenterology Research and Practice. 2014. 1–9. 38 indexed citations
14.
Zhang, Yan, Kan Chen, Weiqi Dai, et al.. (2014). Combination therapy of bezafibrate and ursodeoxycholic acid for primary biliary cirrhosis: A meta‐analysis. Hepatology Research. 45(1). 48–58. 22 indexed citations
15.
Cheng, Ping, Weiqi Dai, Fan Wang, et al.. (2013). Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1–RAGE and AKT pathways. Biochemical and Biophysical Research Communications. 443(4). 1162–1168. 55 indexed citations
16.
Shen, Miao, Jie Lu, Weiqi Dai, et al.. (2013). Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy. Mediators of Inflammation. 2013. 1–12. 76 indexed citations
17.
Zhang, Yan, Jie Lu, Weiqi Dai, et al.. (2013). Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis. Gastroenterology Research and Practice. 2013. 1–9. 21 indexed citations
18.
He, Lei, Fan Wang, Weiqi Dai, et al.. (2013). Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines. Pancreatology. 13(1). 72–78. 37 indexed citations
19.
Wang, Fan, Lei He, Weiqi Dai, et al.. (2012). Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo. PLoS ONE. 7(12). e50638–e50638. 101 indexed citations
20.
Cha, Joonseok, et al.. (2008). Control of WHITE COLLAR localization by phosphorylation is a critical step in the circadian negative feedback process. The EMBO Journal. 27(24). 3246–3255. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026